VRX Insider Trading
Bausch Health Companies Inc. | Pharmaceutical Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Bausch Health Companies Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2013-09-05 00:09 | 2013-09-03 | Provencio Norma Ann | Director | SELL | $99.68 | 5,000 | $498,400 | 167,282 | -2.9% |
| 2013-09-04 00:17 | 2013-08-29 | Hassan Fred | Director | BUY | $99.01 | 51,000 | $5,049,459 | 53,969 | +1,717.8% |
| 2013-08-29 23:46 | 2013-08-27 | Farmer Ronald Harold | Director | BUY | $102.36 | 2,500 | $255,895 | 26,057 | +10.6% |
| 2013-08-23 23:54 | 2013-08-23 | Chai-Onn Robert Roswell | Officer - EVP, GC and Corp. Secretary | BUY | $99.30 | 5,032 | $499,673 | 188,277 | +2.7% |
| 2013-08-13 01:10 | 2013-08-12 | Stolz Brian M. | Officer - EVP, Administration and CHCO | BUY | $100.71 | 4,500 | $453,197 | 32,156 | +16.3% |
| 2013-08-13 01:05 | 2013-08-09 | Kornwasser Laizer | Officer - EVP, Company Group Chairman | BUY | $100.36 | 3,500 | $351,247 | 7,500 | +87.5% |
| 2013-06-22 00:53 | 2013-06-19 | Morfit G Mason | Director, Other | BUY | $85.00 | 1,352,941 | $114,999,985 | 1,352,941 | +100.0% |
| 2013-06-18 23:23 | 2013-06-14 | Segal Lloyd Mitchell | Director | BUY | $85.45 | 140 | $11,963 | 21,174 | +0.7% |
| 2013-06-14 00:35 | 2013-06-11 | Segal Lloyd Mitchell | Director | BUY | $84.17 | 3,190 | $268,486 | 21,034 | +17.9% |
| 2013-06-14 00:14 | 2013-06-11 | Provencio Norma Ann | Director | SELL | $85.26 | 6,000 | $511,557 | 171,860 | -3.4% |
| 2013-03-14 01:03 | 2013-03-11 | Kornwasser Laizer | Officer - EVP, Company Group Chairman | BUY | $70.61 | 2,000 | $141,217 | 2,000 | +100.0% |
| 2012-11-15 05:40 | 2012-11-09 | Segal Lloyd Mitchell | Director | BUY | $54.28 | 240 | $13,027 | 17,849 | +1.4% |
| 2012-11-09 23:53 | 2012-11-08 | DE SILVA RAJIV | Officer - Pres & COO, Specialty Pharm | OPT+S | $54.04 | 76,344 | $4,125,676 | 265,217 | 0.0% |
| 2012-11-08 22:23 | 2012-11-06 | Schiller Howard Bradley | Officer - EVP and CFO | BUY | $54.10 | 18,300 | $990,103 | 182,900 | +11.1% |
| 2012-11-08 22:29 | 2012-11-07 | Stolz Brian M. | Officer - EVP, Administration and CHCO | BUY | $52.76 | 2,040 | $107,622 | 26,650 | +8.3% |
| 2012-11-08 22:17 | 2012-11-06 | Segal Lloyd Mitchell | Director | BUY | $54.44 | 745 | $40,556 | 17,609 | +4.4% |
| 2012-11-09 00:40 | 2012-11-06 | DE SILVA RAJIV | Officer - Pres. & COO, Specialty Pharma | OPT+S | $54.38 | 220,696 | $12,000,875 | 265,217 | 0.0% |
| 2012-06-08 00:38 | 2012-06-05 | ValueAct Holdings, L.P. | Director, Other | BUY | $47.79 | 152,807 | $7,301,928 | 17,559,302 | +0.9% |
| 2012-06-05 23:57 | 2012-06-01 | PAUL LAURENCE E | Director | BUY | $46.85 | 4,300 | $201,455 | 60,459 | +7.7% |
| 2012-06-04 23:59 | 2012-05-31 | ValueAct Holdings, L.P. | Director, Other | BUY | $46.93 | 250,000 | $11,732,000 | 17,406,495 | +1.5% |
| 2012-05-30 23:38 | 2012-05-25 | ValueAct Holdings, L.P. | Director, Other | BUY | $48.16 | 197,193 | $9,496,184 | 17,156,495 | +1.2% |
| 2012-05-30 23:51 | 2012-05-25 | PAUL LAURENCE E | Director | BUY | $48.53 | 5,700 | $276,600 | 48,097 | +13.4% |
| 2012-05-25 00:56 | 2012-05-22 | ValueAct Holdings, L.P. | Director, Other | BUY | $47.18 | 300,000 | $14,153,010 | 16,959,302 | +1.8% |
| 2012-05-25 00:00 | 2012-05-22 | Provencio Norma Ann | Director | BUY | $47.74 | 4,225 | $201,714 | 168,155 | +2.6% |
| 2012-05-21 23:54 | 2012-05-17 | Farmer Ronald Harold | Director | BUY | $49.34 | 2,000 | $98,680 | 10,847 | +22.6% |
| 2012-05-22 03:19 | 2012-05-17 | ValueAct Holdings, L.P. | Director, Other | BUY | $48.21 | 850,000 | $40,981,985 | 16,659,302 | +5.4% |
| 2012-05-22 00:05 | 2012-05-18 | PAUL LAURENCE E | Director | BUY | $47.00 | 5,000 | $235,000 | 42,397 | +13.4% |
| 2012-05-17 02:05 | 2012-05-14 | ValueAct Holdings, L.P. | Director, Other | BUY | $50.98 | 295,000 | $15,039,100 | 15,809,302 | +1.9% |
| 2012-05-15 00:16 | 2012-05-10 | Stolz Brian M. | Officer - EVP, Administration and CHCO | BUY | $53.10 | 5,000 | $265,507 | 20,260 | +32.8% |
| 2012-05-15 00:33 | 2012-05-10 | Masterson Richard Kevin | Officer - Pres. & COO, Valeant Intl. BB | SELL | $52.57 | 4 | $210 | 89,524 | 0.0% |
| 2012-05-15 00:57 | 2012-05-14 | PAUL LAURENCE E | Director | BUY | $51.03 | 5,000 | $255,144 | 37,397 | +15.4% |
| 2012-05-10 23:36 | 2012-05-08 | ValueAct Holdings, L.P. | Director, Other | BUY | $51.00 | 419,000 | $21,369,000 | 15,514,302 | +2.8% |
| 2012-03-09 03:15 | 2012-03-07 | Hall Susan | Officer - Global Head of R&D | OPT+S | $54.50 | 16,120 | $878,513 | 0 | 0.0% |
| 2012-03-09 03:00 | 2012-03-06 | Schiller Howard Bradley | Officer - CFO | BUY | $53.53 | 9,200 | $492,454 | 136,800 | +7.2% |
| 2012-03-06 01:18 | 2012-03-01 | Schiller Howard Bradley | Officer - EVP and CFO | BUY | $53.64 | 18,600 | $997,726 | 127,600 | +17.1% |
| 2011-12-10 01:19 | 2011-12-08 | Schiller Howard Bradley | Officer - EVP and CFO | BUY | $45.51 | 11,000 | $500,606 | 54,500 | +25.3% |
| 2011-12-07 23:55 | 2011-12-05 | Schiller Howard Bradley | Officer - EVP and CFO | BUY | $46.82 | 11,000 | $515,020 | 43,500 | +33.8% |
| 2011-12-06 01:29 | 2011-12-01 | Schiller Howard Bradley | Officer - EVP and CFO | BUY | $46.12 | 32,500 | $1,498,936 | 32,500 | +100.0% |
| 2011-11-18 23:05 | 2011-11-17 | Stolz Brian M. | Officer - EVP Administration & CHCO | BUY | $42.05 | 2,400 | $100,920 | 12,860 | +22.9% |
| 2011-09-14 20:02 | 2011-09-12 | Farmer Ronald Harold | Director | BUY | $39.72 | 1,000 | $39,720 | 8,209 | +13.9% |
| 2011-08-30 23:42 | 2011-08-26 | Stolz Brian M. | Officer - EVP, Administration and CHCO | BUY | $41.00 | 2,680 | $109,880 | 5,230 | +105.1% |
| 2011-08-24 17:21 | 2011-08-19 | Farmer Ronald Harold | Director | BUY | $38.57 | 1,000 | $38,570 | 6,209 | +19.2% |
| 2011-08-24 19:15 | 2011-08-19 | Farmer Ronald Harold | Director | BUY | $38.57 | 1,000 | $38,570 | 7,209 | +16.1% |
| 2011-08-16 23:43 | 2011-08-12 | DE SILVA RAJIV | Officer - President & COO | BUY | $40.40 | 6,180 | $249,666 | 241,758 | +2.6% |
| 2011-08-16 01:56 | 2011-08-11 | Pearson J. Michael | Officer - Chief Executive Officer | BUY | $38.62 | 155,642 | $6,010,770 | 5,570,503 | +2.9% |
| 2011-08-11 22:46 | 2011-08-09 | Farmer Ronald Harold | Director | BUY | $38.63 | 2,000 | $77,250 | 6,209 | +47.5% |
| 2011-08-11 23:18 | 2011-08-09 | Stolz Brian M. | Officer - EVP, Administration and CHCO | BUY | $39.18 | 2,550 | $99,901 | 2,550 | +100.0% |
| 2011-08-11 23:49 | 2011-08-09 | Provencio Norma Ann | Director | BUY | $40.87 | 2,255 | $92,154 | 162,013 | +1.4% |
| 2011-08-10 00:03 | 2011-08-08 | STEVENSON KATHARINE BERGHUIS | Director | BUY | $39.73 | 1,000 | $39,730 | 10,397 | +10.6% |
| 2011-06-13 21:52 | 2011-06-09 | Loberg Philip Walden Jr | Officer - EVP, Interim CFO | BUY | $52.82 | 7,500 | $396,150 | 137,565 | +5.8% |
How to Interpret $VRX Trades
Not every insider transaction in Bausch Health Companies Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $VRX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for VRX
Insider activity data for Bausch Health Companies Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $VRX, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.